News by region
"The UK Government is investing £21m in the National Robotarium to support world-leading research in Scotland"
Staff are overstretched everywhere now, and that impacts collaboration and coordination of care
The report shows a steady growth with some key markets maintaining their position as global leader
“It is a privilege to be called upon to lead one of the communication industry’s foremost health practices.”
Drug development group Hovione has announced that the board of directors and the shareholders have approved the appointment of Dr. Jean-Luc Herbeaux as its new CEO. Guy Villax, who has been Hovione's CEO for the past 25 years will now serve as a member of the board and shareholder. During his tenure, Hovione grew tenfold. [...]
Dr. Jhonatan Bringas Dimitriades on why medical education is struggling to keep pace with health tech advancement and how to fix it.
Imprivata®, the digital identity company for healthcare and beyond, recently recognised partners Softcat, Conecto, Data#3, and SVA with iPartner Awards. Imprivata presented Softcat with the “International iPartner of the Year” award, Conecto with the “European iPartner of the Year” award, Data#3 with the “APAC iPartner of the Year” award and SVA with the “Emerging iPartner [...]
Medtech and biopharma's equivalent of the Nobel Peace Prize - the 2022 Prix Galien Awards - is now open for entries. Organiser, the Galien Foundation, is seeking biopharma and medtech products and innovations which are "making important improvements in the human condition". As in the past, judging will be by a preeminent scientific and learned committee, [...]
Dxcover, developer of liquid biopsies for the early detection of cancer, has secured US patents for its groundbreaking Dxcover Autosampler and the Dxcover Brain Cancer Liquid Biopsy. The Glasgow-based company has developed an alternative approach to traditional blood sampling liquid biopsy for the early detection of cancer through its testing which uses attenuated total [...]
One of Europe's most substantial health tech innovation funds has emerged following the closing of Lauxera's debut fund at more than €260m (£218m). Lauxera Growth I exceeded its initial fundraising target of €150 million, reflecting the strength and depth of the investment opportunities in fast-growing European health tech sector. Lauxera Growth I makes investments in health tech [...]
